The Mercedes Vision AVTR brings one of the brand’s most unusual concept cars onto the streets of Hollywood. Its flowing ...

Add Yahoo as a preferred source to see more of our stories on Google. Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a ...

One morning in mid-January, Diana Pardoe woke to discover that she could not see out of her right eye. "It seemed like there was a grey mist covering it," recalls Pardoe, 60. "I was panicking and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Michelle Fennell was sitting at her desk when her right eye started feeling heavy. Suddenly, it was blurry and her peripheral vision waned. It felt like she was looking through a fishbowl; she could ...

Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

She was taking a GLP-1 drug to lose weight when she woke up one morning with vision loss in her right eye. “It’s been very challenging,” she says. Here’s what doctors say about the risk. Hundreds of ...

Looking ahead to 2030, our model projects AVTR could trade at an average price of $20.83, with a potential range between $15.62 and $26.04. This represents a potential 35.4% return from today’s price.

Several people in the US have sued the companies behind popular GLP-1 drugs such as Ozempic and Mounjaro, alleging that the medicines caused a rare eye condition that can lead to permanent vision loss ...

Two pharmaceutical giants that produce GLP-1 weight-loss drugs are facing lawsuits filed by people who claim their vision loss was caused by the medications. The lawsuits claim Novo Nordisk, the maker ...